Ebselen Is a Potential Anti-Osteoporosis Agent by Suppressing Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Osteoclast Differentiation In vitro and Lipopolysaccharide-Induced Inflammatory Bone Destruction In vivo

Ebselen is a non-toxic seleno-organic drug with anti-inflammatory and antioxidant properties that is currently being examined in clinical trials to prevent and treat various diseases, including atherosclerosis, stroke, and cancer. However, no reports are available for verifying the pharmacological e...

Descripción completa

Detalles Bibliográficos
Autores principales: Baek, Jong Min, Kim, Ju-Young, Yoon, Kwon-Ha, Oh, Jaemin, Lee, Myeung Su
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807414/
https://www.ncbi.nlm.nih.gov/pubmed/27019631
http://dx.doi.org/10.7150/ijbs.13815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807414/
https://www.ncbi.nlm.nih.gov/pubmed/27019631
http://dx.doi.org/10.7150/ijbs.13815

Ejemplares similares